IP Library › Assignment 025333/0026
Patent Assignment
Reel/Frame 025333/0026

Security Agreement

Recorded: 2010-11-09 Pages: 28
Assignor
BIOLEX THERAPEUTICS, INC.
Executed: 2010-10-01
Assignee
MIDCAP FINANCIAL SBIC, LP
7735 OLD GEORGETOWN ROAD, SUITE 400, BETHESDA, MARYLAND, 20814
Covered Properties (45)
Plate and Method for High Throughput Screening
Use of Duckweed in High Throughput Screening
Led Array for Illuminating Cell Well Plates and Automated Rack System for Handling the Same
Alpha Interferon Variants
Expression of Biologically Active Polypeptides in Duckweed
Bioreactor for Growing Biological Materials Supported on a Liquid Surface
Expression of Plasminogen and Microplasminogen in Duckweed
C-Terminaly Truncated Interferon
Monoclonal Antibodies Against CD30 Lacking in Fucosyl and Xylosyl Residues
Expression Control Elements from the Lemnaceae Family
Compositions and Methods for Humanization and Optimization of N-Glycans in Plants
Compositions and Methods for Humanization and Optimization of N-Glycans in Plants
Bioreactor for Growing Biological Materials Supported on a Liquid Surface
Controlled Release Interferon Drug Products and Treatment of Hcv Infection Using Same
Humanized Anti-CD20 Antibodies and Methods of Use
Aseptic Bioreactor System for Processing Biological Materials
Polyetherester Copolymers as Drug Delivery Matrices
Patent: 5,980,948 →
Application: 08/699,896 →
Expression of Biologically Active Polypeptides in Duckweed
Patent: 6,815,184 →
Application: 09/915,873 →
Publication: US 2002/0088027
Led Array for Illuminating Cell Well Plates and Automated Rack System for Handling the Same
Patent: 6,680,200 →
Application: 10/080,918 →
Publication: US 2003/0162288
Plate and Method for High Throughput Screening
Patent: 7,326,385 →
Application: 10/157,562 →
Publication: US 2003/0026738
Use of Duckweed in High Throughput Screening
Patent: 7,709,699 →
Application: 10/158,243 →
Publication: US 2003/0033630
C-Terminally Truncated Interferon Alpha Variants
Patent: 7,959,910 →
Application: 10/574,046 →
Publication: US 2007/0128162
Expression of Biologically Active Polypeptides in Duckweed
Patent: 8,022,270 →
Application: 10/675,011 →
Publication: US 2006/0195946
Expression of Monoclonal Antibodies in Duckweed
Patent: 7,632,983 →
Application: 10/794,615 →
Publication: US 2004/0261148
Bioreactor for Growing Biological Materials Supported on a Liquid Surface
Patent: 7,176,024 →
Application: 10/845,914 →
Publication: US 2004/0259239
Expression of Plasminogen and Microplasminogen in Duck Weed
Patent: 7,659,445 →
Application: 11/056,621 →
Publication: US 2005/0262592
Bioreactor for Growing Biological Materials Supported on a Liquid Surface
Application: 11/469,663 →
Publication: US 2007/0113474
Bioreactor for Growing Biological Materials Supported on a Liquid Surface
Application: 11/469,675 →
Publication: US 2007/0094926
Compositions and Methods for Inhibition of Fucosyltransferase and Xylosyltransferase Expression in Plants
Patent: 8,716,557 →
Application: 11/624,158 →
Publication: US 2008/0060092
Compositions and Methods for Inhibition of Fucosyltransferase and Xylosyltransferase Expression in Duckweed Plants
Patent: 7,884,264 →
Application: 11/624,164 →
Publication: US 2008/0066200
Expression Control Elements from the Lemnaceae Family
Patent: 7,622,573 →
Application: 11/653,593 →
Publication: US 2007/0180583
Controlled Release Compositions for Interferon Based on Pegt/Pbt Block Copolymers
Patent: 7,736,674 →
Application: 11/774,107 →
Publication: US 2008/0008733
Expression of Biologically Active Polypeptides in Duckweed
Application: 11/778,480 →
Publication: US 2009/0282584
C-Terminally Truncated Interferon
Patent: 7,915,483 →
Application: 11/874,607 →
Publication: US 2009/0025106
Glycan-Optimized Anti-CD20 Antibodies
Application: 12/115,133 →
Publication: US 2009/0060921
Monoclonal Antibodies Against CD30 Lacking in Fucosyl and Xylosyl Residues
Application: 12/160,990 →
Publication: US 2009/0175886
Controlled Release Interferon Drug Products and Treatment of Hcv Infections Using Same
Patent: 8,137,661 →
Application: 12/180,214 →
Publication: US 2009/0068280
Controlled Release Compositions for Interferon Based on Pegt/Pbt Block Copolymers and Method for Preparation Thereof
Patent: 7,867,518 →
Application: 12/466,430 →
Publication: US 2009/0226532
Expression Control Elements from the Lemnaceae Family
Patent: 8,034,916 →
Application: 12/581,752 →
Publication: US 2010/0043099
Controlled Release Compositions for Interferon Based on Pegt/Pbt Block Copolymers and Method for Preparation Thereof
Patent: 8,163,307 →
Application: 12/625,929 →
Publication: US 2010/0074868
Humanized Anti-CD20 Antibodies and Methods of Use
Application: 12/720,483 →
Publication: US 2010/0303808
Aseptic Bioreactor System for Processing Biological Materials
Application: 61/153,451 →
Compositions and Methods for Production of Aglycosylated Plasminogen
Application: 61/181,170 →
Methods and Compositions for the Cryopreservation of Duckweed
Application: 61/219,578 →
Stabilized Interferon Formulations
Application: 61/285,589 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 13, 1997
From: HENNINK, WIM E.
To: OSTEOTECH, INC.
Reel/Frame 008308/0739 →
Assignment of Assignor's Interest Apr 6, 1999
From: GOEDEMOED, JAAP H.
To: OSTEOTECH, INC.
Reel/Frame 009881/0949 →
Assignment of Assignor's Interest Jan 11, 2002
From: STOMP, ANNE-MARIE; DICKEY, LYNN; GASDASKA, JOHN
To: BIOLEX, INC.
Reel/Frame 012464/0089 →
Assignment of Assignor's Interest Aug 19, 2002
From: EVERETT, KEITH
To: BIOLEX, INC.
Reel/Frame 013197/0574 →
Assignment of Assignor's Interest Sep 16, 2002
From: STOMP, ANNE-MARIE; DICKEY, LYNN; HOUGHTELING, BILLY; RAJBHANDARI, NIRMALA
To: BIOLEX, INC.
Reel/Frame 013286/0517 →
Assignment of Assignor's Interest Dec 9, 2002
From: OSTEOTECH, INC.
To: ISOTIS N.V.
Reel/Frame 013552/0219 →
Security Interest Dec 16, 2002
From: BIOLEX, INC.
To: INTERSOUTH PARTNERS IV, L.P. AS ATTORNEY-IN-FACT FOR THE SECURED PARTIES PURSUANT TO THE SECURITY AGREEMENTS
Reel/Frame 013570/0981 →
Assignment of Assignor's Interest Mar 3, 2003
From: EVERETT, KEITH
To: BIOLEX, INC.
Reel/Frame 013801/0411 →
Assignment of Assignor's Interest Jul 21, 2003
From: ISOTIS N. V.
To: CHIENNA B.V.
Reel/Frame 013813/0387 →
Termination of Security Interest Nov 17, 2003
From: INTERSOUTH PARTNERS IV, L.P., AS ATTORNEY-IN-FACT FOR THE SECURED PARTIES PURSUANT TO THE SECURITY AGREEMENTS
To: BIOLEX, INC.
Reel/Frame 014692/0879 →
Assignment of Assignor's Interest Feb 17, 2004
From: DICKEY, LYNN; GASDASKA, JOHN; COX, KEVIN
To: BIOLEX, INC.
Reel/Frame 014979/0212 →
Assignment of Assignor's Interest Jul 30, 2004
From: DICKEY, LYNN F.; GASDASKA, JOHN R.; COX, KEVIN M.; PEELE, CHARLES G.
To: BIOLEX, INC.
Reel/Frame 015025/0533 →
Assignment of Assignor's Interest Jul 21, 2005
From: SPENCER, DAVID; DICKEY, LYNN F.; GASDASKA, JOHN R.; WANG, XIAOWEI
To: BIOLEX, INC.
Reel/Frame 016555/0052 →
Assignment of Assignor's Interest Feb 14, 2007
From: EVERETT, KEITH; JOHNSTON, EUGENE
To: BIOLEX, INC.
Reel/Frame 018888/0018 →
Assignment of Assignor's Interest Jun 22, 2007
From: DICKEY, LYNN; GASDASKA, JOHN; COX, KEVIN
To: BIOLEX, INC.
Reel/Frame 019467/0826 →
Assignment of Assignor's Interest Sep 19, 2007
From: DICKEY, LYNN F.; COX, KEVIN M.; PEELE, CHARLES G.
To: BIOLEX, INC.
Reel/Frame 019846/0320 →
Change of Name Feb 12, 2008
From: BIOLEX, INC.
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 020487/0980 →
Security Agreement May 30, 2008
From: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
To: LSP III OMNI INVESTMENT COOPERATIEF U.A.; S.R. ONE, LIMITED
Reel/Frame 021018/0559 →
Assignment of Assignor's Interest Jul 1, 2008
From: DICKEY, LYNN F.; COX, KEVIN M.; PEELE, CHARLES G.
To: BIOLEX, INC.
Reel/Frame 021179/0685 →
Assignment of Assignor's Interest Jul 1, 2008
From: WANG, MING-BO
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 021179/0297 →
Assignment of Assignor's Interest Jul 1, 2008
From: WANG, MING-BO
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 021179/0644 →
Assignment of Assignor's Interest Jul 2, 2008
From: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
To: BIOLEX, INC.
Reel/Frame 021182/0783 →
Assignment of Assignor's Interest Jul 3, 2008
From: DICKEY, LYNN F.; COX, KEVIN M.; PEELE, CHARLES G.
To: BIOLEX, INC.
Reel/Frame 021195/0646 →
Security Agreement Jul 15, 2008
From: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 021230/0881 →
Termination of Security Interest Oct 14, 2008
From: BIOLEX THERAPEUTICS, INC.
To: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
Reel/Frame 021701/0168 →